A new aplysiatoxin derivative, oscillatoxin I, was isolated from the marine cyanobacterium *Moorea producens*. Oscillatoxin I showed cytotoxicity and diatom growth-inhibition activity.

1. Introduction {#sec1-toxins-11-00366}
===============

The marine cyanobacterium *Lyngbya majuscula* is known to produce aplysiatoxins \[[@B1-toxins-11-00366],[@B2-toxins-11-00366]\] and lyngbyatoxins \[[@B3-toxins-11-00366],[@B4-toxins-11-00366]\], which cause severe contact dermatitis \[[@B1-toxins-11-00366],[@B3-toxins-11-00366]\]. Contact dermatitis due to *L. majuscula* has been reported in tropical and subtropical waters, especially in the Pacific region \[[@B5-toxins-11-00366],[@B6-toxins-11-00366]\]. Aplysiatoxin and lyngbyatoxin have also caused food poisoning via the ingestion of the red alga *Gracilaria coronopifolia* \[[@B7-toxins-11-00366]\] and the green turtle *Chelonia mydas* \[[@B8-toxins-11-00366]\], respectively. Recently, blooms of *L. majuscula* have been increasing worldwide, threatening human health and eco-systems; this increase is presumably due to climate change \[[@B9-toxins-11-00366]\]. In Japan, several blooms of *L. majuscula* have also been recorded. During the summer of 2010, a mass occurrence of *Moorea producens* (formerly *L. majuscula*) was observed in the Okinawa Prefecture and lasted for almost one month. A cyanobacterial sample collected at this site during the 2010 mass occurrence was used in this study. In a recent study, we identified 15 aplysiatoxin derivatives in this Okinawan cyanobacteria sample \[[@B10-toxins-11-00366]\]. Aplysiatoxins have been shown to act as protein kinase C (PKC) activators and potent tumor promoting compounds \[[@B11-toxins-11-00366],[@B12-toxins-11-00366],[@B13-toxins-11-00366],[@B14-toxins-11-00366],[@B15-toxins-11-00366]\]; their toxicity results from their high PKC activation potency \[[@B11-toxins-11-00366],[@B12-toxins-11-00366],[@B13-toxins-11-00366],[@B14-toxins-11-00366],[@B15-toxins-11-00366]\]. The compound bryostatin-1, which is obtained from the marine bryozoan *Bugula neritina* \[[@B16-toxins-11-00366]\], is also a potent PKC activator \[[@B17-toxins-11-00366]\]. However, bryostatin-1 has low tumor-promoting activity and potent anti-cancer activity \[[@B17-toxins-11-00366],[@B18-toxins-11-00366]\]. Therefore, bryostatin-1 has been recognized as a lead compound against various cancers \[[@B18-toxins-11-00366]\]. The regulation of PKC activity has been shown to be a valuable therapeutic strategy for producing anti-cancer drugs \[[@B19-toxins-11-00366],[@B20-toxins-11-00366]\]. For example, simplified analogues of aplysiatoxin have been shown to exhibit anti-cancer activity \[[@B21-toxins-11-00366],[@B22-toxins-11-00366]\]. Thus, aplysiatoxins are attractive compounds due to their unique activities. So far, many aplysiatoxins have been isolated and reported from marine cyanobacteria \[[@B23-toxins-11-00366],[@B24-toxins-11-00366],[@B25-toxins-11-00366],[@B26-toxins-11-00366],[@B27-toxins-11-00366],[@B28-toxins-11-00366],[@B29-toxins-11-00366]\]. We have also continued to isolate aplysiatoxin-related compounds from the Okinawan *M. producens* sample. In this paper, the isolation, structural elucidation, and bioactivities of a new aplysiatoxin derivative, oscillatoxin I (**1**, [Figure 1](#toxins-11-00366-f001){ref-type="fig"}), are discussed.

2. Results {#sec2-toxins-11-00366}
==========

The frozen sample of the marine cyanobacterium *M. producens* was extracted using MeOH. The obtained methanol extract was subjected to successive separation steps, and finally purified by HPLC using an octadecyl C18 column to yield compound **1** (1.1 mg).

2.1. Structural Elucidation of Compound ***1*** {#sec2dot1-toxins-11-00366}
-----------------------------------------------

Compound **1** was isolated as a colorless solid (\[α\]~D~^17^ +19 (c 0.01, MeOH)). The ^1^H NMR spectrum ([Figure S1](#app1-toxins-11-00366){ref-type="app"}) showed that compound **1** was an aplysiatoxin-related compound. The molecular formula of compound **1** was deduced to be C~32~H~43~BrO~8~ (\[M−H\]^−^ 635.2174 and 637.2173, calcd. 635.2220 and 637.2200) ([Figure S2](#app1-toxins-11-00366){ref-type="app"}), suggesting that compound **1** contained a bromophenol side chain similar to aplysiatoxin. The UV maxima at 228 nm (ε 15,880) and 275 nm (ε 8,190) suggested that compound **1** contained not only a bromophenol chromophore, but also a conjugated system. The HSQC spectra ([Figure S3](#app1-toxins-11-00366){ref-type="app"}) of compound **1** showed seven methyls (two singlets, four doublets, and a methoxy), four methylenes, three methines bonded to methyls in the aliphatic region, four oxygenated methines, two olefinic methines, and three aromatic protons in the bromophenol side chain and nine quaternary (one aliphatic, two olefinic, three aromatic in the bromophenol, two esters, and one ketone) carbons ([Table 1](#toxins-11-00366-t001){ref-type="table"}). The carbon signal at δ~C~ 197.4 and an HMBC ([Figure S4](#app1-toxins-11-00366){ref-type="app"}) correlation from Me-26 (δ~H~ 1.08) to the ketone suggested that compound **1** was related to 17-bromo-30-methyloscillatoxin D (**2**) \[[@B10-toxins-11-00366],[@B23-toxins-11-00366]\]. Analogously to 17-bromo-30-methyloscillatoxin D (**2**), connectivity was observed between the H-4 (Me-26) and H~2~-5 protons in the ^1^H--^1^H COSY spectrum ([Figure 2](#toxins-11-00366-f002){ref-type="fig"}, [Figure S5](#app1-toxins-11-00366){ref-type="app"}), although the methine singlet of H-2 in 17-bromo-30-methyloscillatoxin D was not observed. HMBC correlations were observed between Me-26 and C-3, and between Me-24 and Me-25 and a quaternary carbon (C-7). The carbon chemical shifts of C-2 at δ~C~ 130.0 and C-7 at δ~C~ 164.0 suggested that these quaternary carbons were olefinic carbons in a conjugated system. These observations revealed that compound **1** contained a cyclohexenone structure. A partial structure from H-8 to H-12 was assigned by analysis the ^1^H--^1^H COSY spectrum. The proton chemical shifts of H-8 and H-9 suggested that these peaks corresponded to olefinic protons; these peaks were shifted downfield from δ~H~ 5.78 and δ~H~ 5.52 in 17-bromo-30-methyloscillatoxin D (**2**) \[[@B10-toxins-11-00366]\] to δ~H~ 6.19 and δ~H~ 6.07 in compound **1**, respectively. In addition to this, HMBC correlations between H-8 and C-2/C-7 were observed. This indicated that H-8 and H-9 also belonged to the conjugated system. The hydroxy proton observed at δ~H~ 3.50 was coupled to H-11, apparently indicating that the hydroxy group was located on C-11. The position of the hydroxy group and the unsaturation number (11) indicated the absence of a six-membered ether ring in compound **1**. The methoxy (Me-32) proton at δ~H~ 3.22 was confirmed to be bonded to C-15 via the HMBC spectrum. The existence of a γ-lactone was deduced from the unsaturation number and the proton chemical shift of H-30 at δ~H~ 4.84, which was close to that of the corresponding peak in 17-bromo-30-methyloscillatoxin D (δ~H~ 4.81) \[[@B10-toxins-11-00366]\]. The HMBC correlation between H-29 at δ~H~ 5.54 and C-1 (δ~C~ 166.6) confirmed the existence of an ester linkage between C-1 and C-29. The proton coupling constants of 4.8 Hz for H-4/H-5b and 13.7 Hz for H-4/H-5a rationalized the equatorial orientation of Me-26 on C-4. The large proton coupling constant (16 Hz) indicated an *E* configuration of Δ^8^. The proton coupling constants of H-11 (11.3 and 1.2 Hz) were similar to those of H-11 in aplysiatoxins that have six-membered ether rings, which suggested that the conformations of H-10-H-11 and H-11-H-12 in compound **1** were likely anti and gauche, respectively, like in aplysiatoxin and its derivatives. The structure of compound **1** is shown in [Figure 1](#toxins-11-00366-f001){ref-type="fig"}. Previously, we reported compounds **3** and **4** as oscillatoxin E and F, respectively \[[@B10-toxins-11-00366]\]. However, the same nomenclature (oscillatoxin E and F) was applied to different aplysiatoxin derivatives by Tang et al. at almost the same time \[[@B29-toxins-11-00366]\]. To avoid confusion, we have renamed compounds **3** and **4** oscillatoxin G and H, respectively. Furthermore, compound **1** was designated as oscillatoxin I.

2.2. Biological Activity of Oscillatoxin I *(**1**)* {#sec2dot2-toxins-11-00366}
----------------------------------------------------

Oscillatoxin I (**1**) showed 100% inhibition activities in both cytotoxicity and diatom growth inhibition tests at a concentration of 10 µg/mL. The IC~50~ values of oscillatoxin I (**1**) in the cytotoxicity test and diatom growth inhibition test were 4.6 µg/mL and 1.2 µg/mL, respectively.

3. Discussion {#sec3-toxins-11-00366}
=============

Oscillatoxin I (**1**) is an aplysiatoxin analog that lacks a six-membered ether ring in the molecule. The characteristic bicyclo ring systems of aplysiatoxin and its known derivatives have been proposed to be biosynthesized from a common intermediate \[[@B10-toxins-11-00366]\]. The formation of the ring system of 17-bromo-30-methylosicllatoxin D (**2**) is preceded by an intramolecular aldol reaction between C-2 and C-7 and the dehydration of H-2/7-OH to generate a conjugated ketone, followed by an intramolecular Michael-type addition of 11-OH to C-7 ([Figure 3](#toxins-11-00366-f003){ref-type="fig"}). The presence of a cyclohexenone ring in oscillatoxin I (**1**) suggests that the biosynthesis of oscillatoxin I branches from a biosynthetic intermediate of 17-bromo-30-methyloscillatoxin D (**2**). The biosynthesis of oscillatoxin I is presumed to occur as follows: the aldol reaction of C-2/C-7 followed by the dehydration of H-2/7-OH and H-8/9-OH leads to the biosynthesis of oscillatoxin I. The *E* configuration of Δ^8^ prevents the Michael-type addition of 11-OH to C-7. Therefore, the isolation of oscillatoxin I (**1**) reinforced our proposal regarding the biosynthesis of aplysiatoxin derivatives \[[@B10-toxins-11-00366]\].

Osillatoxin I (**1**) showed moderate toxicity in the cytotoxicity test (IC~50~; 4.6 µg/mL) and diatom growth inhibition test (IC~50~; 1.2 µg/mL). We also studied the toxicities of aplysiatoxin and its fourteen derivatives, and found they had mild activities in these bioactivity tests \[[@B10-toxins-11-00366]\]. Oscillatoxin I showed one of the most potent toxicities among aplysiatoxin and its analogues in the cytotoxicity and diatom growth inhibition tests.

4. Materials and Methods {#sec4-toxins-11-00366}
========================

4.1. General Procedure {#sec4dot1-toxins-11-00366}
----------------------

HPLC was performed using a Hitachi Chromaster HPLC System (Hitachi High-Tech Science Co., Tokyo, Japan). HR-ESI-MS spectral data were collected using a Bruker micrOTOF QII (Bruker Co., Bremen, Germany) mass spectrometer. NMR spectra were recorded in acetone-*d~6~* using a Bruker AVANCE III 600 spectrometer. Optical rotations were measured using a JASCO P-2100 (JASCO Co., Tokyo, Japan) using a 10 mm length cell. UV spectra were measured using a JASCO V-550 UV-spectrometer (JASCO Co., Tokyo, Japan). Bioassay results were recorded on a Model 550 microplate reader (Bio-Rad, Hercules, CA, USA).

4.2. Marine Cyanobacterium M. producens {#sec4dot2-toxins-11-00366}
---------------------------------------

Samples of the marine cyanobacterium *M. producens* were collected from Kuba Beach, Nakagusuku, Okinawa, Japan in July of 2010. After freeze-drying, the samples were stored at −30 °C until the experiments were performed. Identification of the sample was accomplished via morphological observation under a microscope by Dr. Masayuki Fukuoka of Tokyo University of Marine Science and Technology. *Moorea producens* was a dominant cyanobacteria species in the sample. The sample also contained some unidentified diatoms.

4.3. Isolation of Oscillatoxin I {#sec4dot3-toxins-11-00366}
--------------------------------

A frozen sample of the cyanobacterium *M. producens* (dry weight: 0.87 kg) was soaked for several days in ethanol at room temperature. After filtering the ethanol extract, it was extracted five times with methanol and once with acetone. The extracts were then combined and concentrated in vacuo to yield a residue (37.8 g), which was partitioned first between methanol/water (4:1, v/v) and hexane. The solvent of the 80% MeOH-soluble layer was then removed, and the remaining sample was partitioned using distilled water and ethyl acetate (EtOAc). The EtOAc layer was evaporated to dryness. The distilled-water layer was then dissolved with 1-butanol (BuOH) and separated into two extracts. Since the EtOAc layer of the extracts from the cyanobacterium *M. producens* showed the most potent bioactivity, this layer was separated using an open glass column (PEGASIL ODS, Senshu Co., Tokyo, Japan) measuring 20 × 120 mm with stepwise elution in 50%, 70%, 90%, and 100% methanol. The 70% methanol eluate was then purified via HPLC using a reversed-phase column (Cosmosil 5C18-AR-II, 10 × 250 mm, Nakalai Tesque Inc., Kyoto, Japan). Finally, oscillatoxin I (**1**, 1.1 mg) was isolated.

4.4. Biological Tests of Oscillatoxin I {#sec4dot4-toxins-11-00366}
---------------------------------------

Cytotoxicity assays against mouse L1210 leukemia cells were carried out for the isolated compounds. The growth inhibition activity of the compounds against the marine diatom *Nitzschia amabilis* were also evaluated. Both types of bioactive assays were performed using the XTT colorimetric reaction method as previously reported \[[@B30-toxins-11-00366],[@B31-toxins-11-00366]\].
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The following are available online at <https://www.mdpi.com/2072-6651/11/6/366/s1>, Figure S1: ESI-HRMS spectrum of oscillatoxin G in positive ion mode. Figure S2: ^1^H NMR spectrum of oscillatoxin I in acetone- *d~6~.* Figure S3: ^13^C NMR spectrum of oscillatoxin I in acetone- *d~6~*. Figure S4: ^1^H--^1^H COSY NMR spectrum of oscillatoxin I in acetone- *d~6~*. Figure S5: ^1^H--^13^C HSQC spectrum of oscillatoxin I in acetone- *d~6~*. Figure S6: ^1^H--^13^C HMBC spectrum of oscillatoxin I in acetone- *d~6~*.
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###### 

NMR data for oscillatoxin I in acetone-*d*~6~ (600 MHz for ^1^H and 150 MHz for ^13^C).

  --------------------------------------------------------------------------------------
  No.   δ~H~ Multiplicity\     δ~C~          No.     δ~H~ Multiplicity\    δ~C~
        (*J* in Hz)                                  (*J* in Hz)           
  ----- ---------------------- ------------- ------- --------------------- -------------
  1     \-                     166.6, C      17      \-                    111.1, C

  2     \-                     130.0, C      18      7.38 d (8.6)          133.4, CH

  3     \-                     197.4, C      19      6.73 dd (3.1, 8.6)    116.3, CH

  4     2.66 m                 37.1, CH      20      \-                    157.6, C

  5a    1.75 dd (13.7, 13.7)   45.3, CH~2~   21      6.97 d (3.0)          114.2, CH

  5b    1.86 dd (4.8, 13.4)    \-            22      0.94 d (6.6)          13.8, CH~3~

  6     \-                     35.8, C       23      1.05 d (6.9)          17.4, CH~3~

  7     \-                     164.0, C      24      1.21 s                28.3, CH~3~

  8     6.19 dd (0.8, 16.0)    125.4, CH     25      1.31 s                24.7, CH~3~

  9     6.07 dd (8.6, 16.0)    124.2, CH     26      1.08 d (6.6)          13.9, CH~3~

  10    2.49 m                 41.4, CH      27      \-                    174.1, C

  11    3.25 dd (1.2, 11.3)    77.6, CH      28a     2.66 dd (1.1, 18.1)   36.3, CH~2~

  12    1.61 m                 24.7, CH      28b     3.07 dd (6.0, 18.1)   \-

  13a   1.59 m                 35.4, CH~2~   29      5.54 m                72.4, CH

  13b   1.59 m                 \-            30      4.84 m                78.7, CH

  14a   1.67 m                 34.1, CH~2~   31      1.43 d (6.6)          13.9, CH~3~

  14b   1.67 m                 \-            32      3.22 s                56.4, CH~3~

  15    4.47 dd (4.5, 7.5)     82.2, CH      11-OH   3.50 d (5.7)          \-

  16    \-                     143.0, C      20-OH   8.55 s                \-
  --------------------------------------------------------------------------------------
